Response to article by Matthew Wasserman et al. (2018): “Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico”

In a recent article, Wasserman et al. estimated and forecasted the health and economic impact of switching from the 13-valent (PCV-13) to the 10-valent (PHiD-CV) pneumococcal conjugate vaccine in Mexico’s national immunization program. In this response letter, we highlight various methodological inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Jorge A., Guzman Holst, Adriana, Nieto, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Reply Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988871/
https://www.ncbi.nlm.nih.gov/pubmed/30570428
http://dx.doi.org/10.1080/21645515.2018.1554974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988871/
https://www.ncbi.nlm.nih.gov/pubmed/30570428
http://dx.doi.org/10.1080/21645515.2018.1554974

Ejemplares similares